Meloxicam can raise your blood pressure, though the increase is usually modest. As a COX-2–preferential nonsteroidal anti-inflammatory drug, meloxicam shares the blood-pressure-raising tendency common to the broader NSAID class, driven mainly by the way it affects how your kidneys handle sodium and water. The size of the bump and whether it matters clinically depend on factors like your baseline blood pressure, kidney function, and what other medications you take. The story gets more nuanced when you compare meloxicam head-to-head with other painkillers in its class.
Why NSAIDs Push Blood Pressure Up
To understand what meloxicam does, you need to know what it blocks. Meloxicam targets an enzyme called COX-2, which plays a central role in inflammation but also has a day job in your kidneys. COX-2 helps regulate how much sodium your kidneys excrete, influences the release of renin (a hormone that controls blood vessel constriction and fluid balance), and likely opposes the effects of antidiuretic hormone, which tells your body to hold on to water.1PubMed. COX-2 and the kidneys When you inhibit COX-2 with meloxicam, the kidneys start retaining more sodium and, with it, more water. That extra fluid in your bloodstream translates into higher pressure against your artery walls.
This sodium-retention effect kicks in quickly. In controlled research-center settings, COX-2 inhibitors consistently reduced urinary sodium excretion within the first 72 hours of use.2Electrolytes & Blood Pressure. Renal Effects of Prostaglandins and Cyclooxygenase-2 Inhibitors That same source notes that traditional (nonselective) NSAIDs cause peripheral edema, the puffy-ankles kind of fluid retention, in up to about 5% of the general population, and COX-2 inhibitors cause occasional sodium retention even in people with otherwise healthy kidneys. In most people, the body compensates over days to weeks by adjusting other hormonal signals, so the blood pressure increase is often transient or small. But in people whose compensatory systems are already strained, the effect can be more pronounced and persistent.
How Much Does Meloxicam Raise Blood Pressure?
Putting exact numbers on the increase is tricky because study designs, populations, and durations vary. The best general estimate comes from pooled analyses of COX-2 inhibitors as a class. A meta-analysis published in Archives of Internal Medicine found that COX-2 inhibitors raised systolic blood pressure by roughly 4 mm Hg and diastolic by about 1 mm Hg compared with placebo. Against traditional nonselective NSAIDs, the COX-2 group still ran about 3 mm Hg higher on the systolic side.3Archives of Internal Medicine. Meta-analysis of Cyclooxygenase-2 Inhibitors and Their Effects on Blood Pressure That same analysis found a trend toward a higher relative risk of developing hypertension with coxibs, though the increase didn’t reach statistical significance in the pooled data.
A rise of 3 to 4 mm Hg systolic might sound trivial, but context matters. If your resting blood pressure is 118/76, a few extra points probably won’t change your health outlook. If you’re already sitting at 138/88, that nudge could push you firmly into the hypertensive range and raise your long-term risk of heart attack and stroke. The clinical significance depends entirely on where you start.
An important caveat: that meta-analysis lumped several COX-2 inhibitors together, including rofecoxib (Vioxx), which was later pulled from the market due to cardiovascular concerns, and celecoxib (Celebrex). Meloxicam was not the headline drug in most of those trials. When researchers looked at meloxicam specifically, the picture looked somewhat more reassuring, as the next section explains.
How Meloxicam Stacks Up Against Other NSAIDs
Not all NSAIDs carry equal cardiovascular risk, and meloxicam tends to come out comparatively well. A systematic review examining meloxicam’s effects on heart, blood vessel, and kidney outcomes found that other NSAIDs increased the composite risk more than meloxicam did, in a dose-dependent fashion. The ranking from highest to lowest added risk was rofecoxib, then indomethacin, diclofenac, celecoxib, naproxen, and ibuprofen, all above meloxicam.4PubMed. The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review
A separate population-level study compared meloxicam users to users of diclofenac, naproxen, and piroxicam. Using diclofenac as the reference drug, the researchers found that meloxicam was not associated with an increased risk for any of the study outcomes, which included newly diagnosed hypertension.5PubMed. The risk of gastrointestinal bleed, myocardial infarction, and newly diagnosed hypertension in users of meloxicam, diclofenac, naproxen, and piroxicam That doesn’t mean meloxicam carries zero blood-pressure risk. It means that among a group of painkillers all capable of raising blood pressure, meloxicam doesn’t appear to be the worst offender.
One reason meloxicam might fare relatively well is how it affects blood vessels directly. An experimental study in rabbit arteries found that meloxicam did not enhance vasoconstrictor responses to noradrenaline, suggesting it doesn’t amplify the kind of blood vessel clamping that would independently push pressure higher on top of the sodium-retention mechanism.6PubMed. The effect of meloxicam and deendothelisation on vascular responses in the rabbit renal and ear arteries That’s a single animal study rather than a human clinical trial, so the translation to your arteries isn’t guaranteed, but the direction of the finding is consistent with the pattern seen in the human data.
It’s worth noting that meloxicam’s adverse event profile, including rates of peripheral edema and hypertension, has been reported as similar to traditional NSAIDs overall.7Expert Opinion on Pharmacotherapy. Meloxicam So “comparatively better than rofecoxib” is not the same as “safe.” The advantage is relative, not absolute.
Interference with Blood Pressure Medications
For people already taking medication for high blood pressure, the drug interaction angle is as important as meloxicam’s direct effect. NSAIDs, meloxicam included, can blunt the effectiveness of common blood pressure drugs, including ACE inhibitors, angiotensin receptor blockers (ARBs), beta-blockers, and diuretics.8Journal of Veterinary Emergency and Critical Care. Potential interactions between non‐steroidal anti‐inflammatory drugs and other drugs The mechanism is the same sodium-retention pathway: your blood pressure drug is trying to push fluid out or relax your arteries, while the NSAID is working against it by telling your kidneys to hold on to sodium and water.
Diuretics deserve special mention. A study in healthy volunteers examined whether meloxicam interfered with furosemide, a commonly used loop diuretic. The researchers found that meloxicam didn’t change how quickly furosemide was absorbed or cleared, and didn’t significantly affect diuresis overall. However, cumulative urinary sodium excretion over the first eight hours was somewhat lower when meloxicam was taken alongside furosemide, with the ratio of sodium excretion (meloxicam plus furosemide versus furosemide alone) coming in at about 88%.9PubMed. Influence of meloxicam on furosemide pharmacokinetics and pharmacodynamics in healthy volunteers The authors considered the effect small and likely not clinically relevant in healthy volunteers, but added the important qualifier “under the dosing regime studied.” In someone with heart failure, advanced kidney disease, or low blood volume, that same modest reduction could tip the balance.
The practical takeaway: if you’re on blood pressure medication and start meloxicam, your doctor may want to check your blood pressure more frequently for the first few weeks. You might need a dose adjustment on your antihypertensive, or your doctor might suggest a painkiller from a different class altogether.
Who Faces the Greatest Risk
The blood-pressure effects of meloxicam don’t hit everyone equally. Several groups are more vulnerable:
- People with existing hypertension: If your blood pressure is already elevated, even a small additional rise can push you into a riskier zone. The compensatory mechanisms that help normotensive people shrug off a few millimeters of mercury may already be maxed out in someone with chronic high blood pressure.
- People with kidney impairment: Healthy kidneys can partly adapt to COX-2 inhibition over time by adjusting other regulatory pathways. Kidneys that are already compromised have less room to maneuver. COX-2 inhibitors cause sodium retention even in people without renal impairment, so the effect is more pronounced when kidney function is reduced.2Electrolytes & Blood Pressure. Renal Effects of Prostaglandins and Cyclooxygenase-2 Inhibitors
- Older adults: Aging reduces kidney function and the flexibility of the cardiovascular system. The same dose of meloxicam in a 30-year-old and a 75-year-old is doing different things to two very different bodies.
- People on multiple cardiovascular medications: Stacking an NSAID on top of a diuretic and an ACE inhibitor, sometimes called the “triple whammy” in clinical slang, raises the risk of acute kidney injury and blood pressure destabilization beyond what any single interaction would predict.
- People with heart failure or low blood volume: The sodium and water retention caused by COX-2 inhibition can worsen fluid overload in heart failure and counteract the body’s attempts to maintain perfusion in dehydrated or volume-depleted states.8Journal of Veterinary Emergency and Critical Care. Potential interactions between non‐steroidal anti‐inflammatory drugs and other drugs
For a young, otherwise healthy person taking meloxicam for a short course after a sports injury, the blood-pressure effect is rarely a concern. The risk calculus shifts substantially for someone who is older, has chronic conditions, or is taking the drug long-term for arthritis.
Short-Term Versus Long-Term Use
Duration matters. A one-week course of meloxicam for an acute flare-up is a very different situation from daily use over months or years for osteoarthritis. The initial sodium retention that occurs within the first 72 hours may partially resolve as the body adjusts its compensatory mechanisms, so a short course may produce a brief, mild bump in blood pressure that returns to baseline once you stop taking the drug.
Long-term use is where the concern grows. Chronic NSAID exposure keeps the kidneys in a state of ongoing sodium retention, giving the body less opportunity to fully compensate. Over time, blood vessel stiffness, kidney function changes, and sustained fluid expansion can compound the effect. This is one reason doctors generally advise using the lowest effective dose of any NSAID for the shortest duration necessary, advice that applies to meloxicam as much as to any other drug in the class.
Meloxicam is commonly prescribed at 7.5 mg or 15 mg daily. The systematic review that ranked NSAIDs by cardiovascular risk found the risk differences were dose-dependent.4PubMed. The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review So sticking with 7.5 mg when it controls your symptoms adequately, rather than defaulting to 15 mg, is a reasonable strategy for minimizing cardiovascular and renal effects.
Monitoring and Practical Steps
If you’re taking meloxicam and have any of the risk factors mentioned above, checking your blood pressure at home during the first couple of weeks gives you early warning of a meaningful rise. A consistent jump of more than 5 mm Hg systolic over your baseline warrants a conversation with your prescriber. Most pharmacies sell affordable automated cuffs, and the investment pays for itself in peace of mind.
Watch for signs of fluid retention: new or worsening ankle swelling, sudden weight gain (a couple of pounds in a day or two suggests water, not fat), and shortness of breath with activity that didn’t bother you before. These are the visible signals that the sodium-retention mechanism is actively affecting your body.
If you’re on a blood pressure medication and need ongoing anti-inflammatory pain relief, your doctor might consider options outside the NSAID family, such as acetaminophen (which doesn’t carry the same sodium-retention risk), topical NSAIDs (which deliver less drug systemically), or non-pharmacologic approaches like physical therapy and exercise. When an oral NSAID is genuinely the best option for your pain, meloxicam’s comparatively favorable cardiovascular profile within the NSAID class is one argument in its favor, but it shouldn’t be treated as risk-free.
What the Veterinary Literature Adds
An unexpected window into meloxicam’s blood pressure effects comes from veterinary medicine. Cats with chronic kidney disease are often treated with low-dose meloxicam for pain, and because feline kidneys are exquisitely sensitive to drug-induced damage, researchers monitor these animals closely. A study of cats with chronic kidney disease found no statistical difference in systolic blood pressure between cats receiving meloxicam and those receiving a placebo.10PubMed Central. Effects of low-dose meloxicam in cats with chronic kidney disease Kidney function markers, including blood urea nitrogen, creatinine, and glomerular filtration rate, were also unchanged.
You can’t directly extrapolate from cats to humans, of course. Feline COX-2 expression and drug metabolism differ from ours. But the finding is consistent with the broader theme: at low doses, meloxicam’s effects on blood pressure and kidney function are more subtle than you might expect from the “all NSAIDs are dangerous” narrative. The signal to worry about seems to emerge most clearly at higher doses, with longer durations, and in individuals whose cardiovascular or renal systems are already compromised.